Literature DB >> 7911059

Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer.

S M Phillips1, D G Morton, S J Lee, D M Wallace, J P Neoptolemos.   

Abstract

OBJECTIVE: To examine prostate tumours for losses of known or suspected tumour suppressor genes to determine some of the important events in the genesis of this common cancer.
MATERIALS AND METHODS: Paired tumour and blood samples were obtained from 21 patients who underwent transurethral resection of malignant prostate glands for urinary outflow obstruction. Paired tumour and normal tissue (leucocytes) DNA was extracted and examined for possible losses of several known or suspected tumour suppressor genes, using restriction fragment length polymorphism techniques to detect loss of heterozygosity.
RESULTS: Deletions of the retinoblastoma susceptibility gene (RB1) locus were found in six of nine informative cases using two intragenic probes (p68RS2.0 and p123m1.8). The locus related to the familial adenomatous polyposis susceptibility (APC) gene demonstrated loss of heterozygosity in three of seven informative cases using the EF5.44 probe. Losses were also noted in loci on chromosome 10p in four of 19 informative cases (probe cTBQ7), chromosome 10q in eight out of 19 informative cases (probes EFD75 and D10S90) and in 16q in three of 17 informative cases (probe D16S7).
CONCLUSION: These findings suggest that losses of the RB1 and APC tumour suppressor genes and suspected tumour suppressor genes on 10p, 10q and 16q may be important events in the genesis of prostatic tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911059     DOI: 10.1111/j.1464-410x.1994.tb07602.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  13 in total

1.  DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1.

Authors:  D J Steadman; D Giuffrida; E P Gelmann
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  Identification of E2F1 as a positive transcriptional regulator for delta-catenin.

Authors:  Kwonseop Kim; Minsoo Oh; Hyunkyoung Ki; Tao Wang; Sonja Bareiss; M Elizabeth Fini; Dawei Li; Qun Lu
Journal:  Biochem Biophys Res Commun       Date:  2008-02-25       Impact factor: 3.575

3.  Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.

Authors:  Shao-Yong Chen; Gerburg Wulf; Xiao Zhen Zhou; Mark A Rubin; Kun Ping Lu; Steven P Balk
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.

Authors:  J A Macoska; J Xu; D Ziemnicka; T S Schwab; M A Rubin; L Kotula
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 5.  Cancer inflammation and regulatory T cells.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

6.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 7.  Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway.

Authors:  Marcy E Beildeck; Edward P Gelmann; Stephen W Byers
Journal:  Exp Cell Res       Date:  2010-02-06       Impact factor: 3.905

8.  CD4+ lymphocytes modulate prostate cancer progression in mice.

Authors:  Theofilos Poutahidis; Varada P Rao; Werner Olipitz; Christie L Taylor; Erin A Jackson; Tatiana Levkovich; Chung Wei Lee; James G Fox; Zhongming Ge; Susan E Erdman
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

9.  Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.

Authors:  Ceshi Chen; Eija-Riitta Hyytinen; Xiaodong Sun; Heikki J Helin; Pasi A Koivisto; Henry F Frierson; Robert L Vessella; Jin-Tang Dong
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

Authors:  P Koivisto; E Hyytinen; C Palmberg; T Tammela; T Visakorpi; J Isola; O P Kallioniemi
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.